表紙:造影超音波検査の世界市場の予測:2022年~2030年
市場調査レポート
商品コード
1130704

造影超音波検査の世界市場の予測:2022年~2030年

Global Contrast Enhanced Ultrasound Market Forecast 2022-2030

出版日: | 発行: Inkwood Research | ページ情報: 英文 235 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
造影超音波検査の世界市場の予測:2022年~2030年
出版日: 2022年10月03日
発行: Inkwood Research
ページ情報: 英文 235 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の造影超音波検査の市場規模は、2022年~2030年の予測期間中にCAGRで5.25%の成長が予測されています。慢性疾患の増加、診断技術の進歩、医療従事者の造影超音波検査への選好の高まりが、主な成長促進要因となっています。

当レポートでは、世界の造影超音波検査市場について調査分析し、市場全体、市場力学、市場予測、主要セグメント別の評価、地域分析、主要アナリティクス、競合情勢などについて、最新の情報を提供しています。

目次

第1章 調査範囲・調査手法

第2章 エグゼクティブサマリー

第3章 市場力学

  • 主要促進要因
    • 慢性疾患の蔓延
    • 医療従事者の造影超音波検査への選好
    • 診断技術の進歩
  • 主要抑制要因
    • 造影剤の不均一性
    • 現在の医療制度での採用の難しさ

第4章 主要アナリティクス

  • 造影超音波検査に対するCOVID-19の影響
  • 主な市場動向
  • ポーターのファイブフォース分析
  • 機会マトリックス
  • ベンダー情勢
  • バリューチェーン分析
  • 主な購入基準
  • 規制の枠組み

第5章 市場:製品別

  • 装置
  • 造影剤

第6章 市場:タイプ別

  • 非標的型
  • 標的型

第7章 市場:エンドユーザー別

  • 病院
  • クリニック
  • 外来診療センター

第8章 地域分析

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域

第9章 競合情勢

  • 主な戦略的発展
  • 企業プロファイル
    • BAYER AG
    • BRACCO DIAGNOSTIC INC
    • DAIICHI SANKYO COMPANY LIMITED
    • GE HEALTHCARE
    • KONINKLIJKE PHILIPS NV
    • LANTHEUS MEDICAL IMAGING INC
    • NANOPET PHARMA GMBH
    • SANOCHEMIA PHARMAZEUTIKA GMBH
    • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
    • SIEMENS HEALTHINEERS AG
    • TAEJOON PHARM
    • TRIVITRON HEALTHCARE
図表

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. SURGING PREVALENCE OF CHRONIC DISEASES
    • 3.1.2. HEALTH PRACTITIONERS PREFER CONTRAST ENHANCED ULTRASOUND IMAGING
    • 3.1.3. TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSIS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. NON-UNIFORMITY OF CONTRAST AGENTS
    • 3.2.2. DIFFICULTY IN ADOPTION IN THE CURRENT HEALTHCARE SYSTEM

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON CONTRAST ENHANCED ULTRASOUND MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE
  • 4.6. VALUE CHAIN ANALYSIS
  • 4.7. KEY BUYING CRITERIA
    • 4.7.1. COST EFFICIENCY
    • 4.7.2. PRODUCT FEATURES
    • 4.7.3. END-USE
  • 4.8. REGULATORY FRAMEWORK

5. MARKET BY PRODUCT

  • 5.1. EQUIPMENT
  • 5.2. CONTRAST AGENT

6. MARKET BY TYPE

  • 6.1. NON-TARGETED
  • 6.2. TARGETED

7. MARKET BY END-USER

  • 7.1. HOSPITALS
  • 7.2. CLINICS
  • 7.3. AMBULATORY DIAGNOSTIC CENTERS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. MARKET SIZE & ESTIMATES
    • 8.1.2. KEY GROWTH ENABLERS
    • 8.1.3. KEY CHALLENGES
    • 8.1.4. KEY PLAYERS
    • 8.1.5. COUNTRY ANALYSIS
      • 8.1.5.1. UNITED STATES
      • 8.1.5.2. CANADA
  • 8.2. EUROPE
    • 8.2.1. MARKET SIZE & ESTIMATES
    • 8.2.2. KEY GROWTH ENABLERS
    • 8.2.3. KEY CHALLENGES
    • 8.2.4. KEY PLAYERS
    • 8.2.5. COUNTRY ANALYSIS
      • 8.2.5.1. UNITED KINGDOM
      • 8.2.5.2. GERMANY
      • 8.2.5.3. FRANCE
      • 8.2.5.4. ITALY
      • 8.2.5.5. SPAIN
      • 8.2.5.6. NORDIC COUNTRIES
      • 8.2.5.7. REST OF EUROPE
  • 8.3. ASIA-PACIFIC
    • 8.3.1. MARKET ESTIMATES & SIZES
    • 8.3.2. KEY GROWTH ENABLERS
    • 8.3.3. KEY CHALLENGES
    • 8.3.4. KEY PLAYERS
    • 8.3.5. COUNTRY ANALYSIS
      • 8.3.5.1. CHINA
      • 8.3.5.2. JAPAN
      • 8.3.5.3. INDIA
      • 8.3.5.4. SOUTH KOREA
      • 8.3.5.5. INDONESIA
      • 8.3.5.6. SINGAPORE
      • 8.3.5.7. TAIWAN
      • 8.3.5.8. AUSTRALIA & NEW ZEALAND
      • 8.3.5.9. REST OF ASIA-PACIFIC
  • 8.4. REST OF WORLD
    • 8.4.1. MARKET ESTIMATES & SIZES
    • 8.4.2. KEY GROWTH ENABLERS
    • 8.4.3. KEY CHALLENGES
    • 8.4.4. KEY PLAYERS
    • 8.4.5. REGIONAL ANALYSIS
      • 8.4.5.1. LATIN AMERICA
      • 8.4.5.2. MIDDLE EAST & AFRICA

9. COMPETITIVE LANDSCAPE

  • 9.1. KEY STRATEGIC DEVELOPMENTS
    • 9.1.1. MERGERS & ACQUISITIONS
    • 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 9.1.3. PARTNERSHIPS & AGREEMENTS
    • 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
  • 9.2. COMPANY PROFILES
    • 9.2.1. BAYER AG
    • 9.2.2. BRACCO DIAGNOSTIC INC
    • 9.2.3. DAIICHI SANKYO COMPANY LIMITED
    • 9.2.4. GE HEALTHCARE
    • 9.2.5. KONINKLIJKE PHILIPS NV
    • 9.2.6. LANTHEUS MEDICAL IMAGING INC
    • 9.2.7. NANOPET PHARMA GMBH
    • 9.2.8. SANOCHEMIA PHARMAZEUTIKA GMBH
    • 9.2.9. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
    • 9.2.10. SIEMENS HEALTHINEERS AG
    • 9.2.11. TAEJOON PHARM
    • 9.2.12. TRIVITRON HEALTHCARE

LIST OF TABLES

  • TABLE 1: GLOBAL MARKET SNAPSHOT - CONTRAST ENHANCED ULTRASOUND
  • TABLE 2: EXAMPLES OF CURRENT CLINICAL ULTRASOUND CONTRAST AGENTS
  • TABLE 3: EXAMPLES OF EMERGING ULTRASOUND MICROBUBBLES-BASED TECHNIQUES
  • TABLE 4: REGULATORY FRAMEWORK
  • TABLE 5: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 6: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 7: GLOBAL EQUIPMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 8: GLOBAL EQUIPMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 9: GLOBAL CONTRAST AGENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 10: GLOBAL CONTRAST AGENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 11: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 12: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 13: GLOBAL NON-TARGETED MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 14: GLOBAL NON-TARGETED MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 15: GLOBAL TARGETED MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 16: GLOBAL TARGETED MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 17: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 18: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 19: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 20: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 21: GLOBAL CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 22: GLOBAL CLINICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 23: GLOBAL AMBULATORY DIAGNOSTIC CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 24: GLOBAL AMBULATORY DIAGNOSTIC CENTERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 25: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 26: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 27: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 28: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 29: LEADING PLAYERS OPERATING IN NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET
  • TABLE 30: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 31: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 32: LEADING PLAYERS OPERATING IN EUROPE CONTRAST ENHANCED ULTRASOUND MARKET
  • TABLE 33: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 34: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 35: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET
  • TABLE 36: REST OF WORLD CONTRAST ENHANCED ULTRASOUND MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 37: REST OF WORLD CONTRAST ENHANCED ULTRASOUND MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 38: LEADING PLAYERS OPERATING IN REST OF WORLD CONTRAST ENHANCED ULTRASOUND MARKET
  • TABLE 39: LIST OF MERGERS & ACQUISITIONS
  • TABLE 40: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 41: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 42: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: VALUE CHAIN ANALYSIS
  • FIGURE 6: KEY BUYING CRITERIA
  • FIGURE 7: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
  • FIGURE 8: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY EQUIPMENT, 2022-2030 (IN $ MILLION)
  • FIGURE 9: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY CONTRAST AGENT, 2022-2030 (IN $ MILLION)
  • FIGURE 10: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021
  • FIGURE 11: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY NON-TARGETED, 2022-2030 (IN $ MILLION)
  • FIGURE 12: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY TARGETED, 2022-2030 (IN $ MILLION)
  • FIGURE 13: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
  • FIGURE 14: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)
  • FIGURE 15: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY CLINICS, 2022-2030 (IN $ MILLION)
  • FIGURE 16: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY AMBULATORY DIAGNOSTIC CENTERS, 2022-2030 (IN $ MILLION)
  • FIGURE 17: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 18: UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 19: CANADA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 20: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 21: UNITED KINGDOM CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 22: GERMANY CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 23: FRANCE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 24: ITALY CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 25: SPAIN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 26: NORDIC COUNTRIES CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 27: REST OF EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 28: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN%)
  • FIGURE 29: CHINA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 30: JAPAN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 31: INDIA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 32: SOUTH KOREA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 33: INDONESIA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 34: SINGAPORE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 35: TAIWAN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 36: AUSTRALIA & NEW ZEALAND CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 37: REST OF ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 38: REST OF WORLD CONTRAST ENHANCED ULTRASOUND MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 39: LATIN AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 40: MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: VALUE CHAIN ANALYSIS
  • FIGURE 6: KEY BUYING CRITERIA
  • FIGURE 7: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
  • FIGURE 8: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY EQUIPMENT, 2022-2030 (IN $ MILLION)
  • FIGURE 9: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY CONTRAST AGENT, 2022-2030 (IN $ MILLION)
  • FIGURE 10: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021
  • FIGURE 11: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY NON-TARGETED, 2022-2030 (IN $ MILLION)
  • FIGURE 12: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY TARGETED, 2022-2030 (IN $ MILLION)
  • FIGURE 13: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
  • FIGURE 14: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)
  • FIGURE 15: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY CLINICS, 2022-2030 (IN $ MILLION)
  • FIGURE 16: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY AMBULATORY DIAGNOSTIC CENTERS, 2022-2030 (IN $ MILLION)
  • FIGURE 17: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 18: UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 19: CANADA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 20: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 21: UNITED KINGDOM CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 22: GERMANY CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 23: FRANCE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 24: ITALY CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 25: SPAIN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 26: NORDIC COUNTRIES CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 27: REST OF EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 28: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN%)
  • FIGURE 29: CHINA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 30: JAPAN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 31: INDIA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 32: SOUTH KOREA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 33: INDONESIA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 34: SINGAPORE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 35: TAIWAN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 36: AUSTRALIA & NEW ZEALAND CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 37: REST OF ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 38: REST OF WORLD CONTRAST ENHANCED ULTRASOUND MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 39: LATIN AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 40: MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
目次
Product Code: 48391

KEY FINDINGS

The global contrast enhanced ultrasound market is expected to register a CAGR of 5.25% during the forecast period, 2022-2030. The increasing prevalence of chronic disease, advanced technologies for diagnosis, and rising preference for contrast enhanced ultrasound imaging among health practitioners are the primary growth drivers.

MARKET INSIGHTS

Contrast enhanced ultrasound is a medical imaging test that uses intravenous agents containing microbubbles. Contrast helps providers view the blood flow through blood vessels and organs. Chronic diseases are on the rise worldwide, pressurizing the health systems working diligently to deliver high-quality chronic care management. Simultaneously, several public health programs are pushing for periodic screening examinations to detect specific chronic diseases. For instance, cardiovascular diseases, diabetes, and cancer. Accordingly, new delivery models and advancements in precise diagnosis and detection of disease are evaluated to reduce the cost of treating chronic conditions.

Furthermore, the extensive use of contrast enhanced ultrasound is a measure that has facilitated a major breakthrough in diagnostic ultrasound. It projects the micro- and macro-circulation of the targeted organ. It is commonly used in oncology to delineate information like blood flow, location, and tumor size. As a result, the surging prevalence of chronic diseases is a major growth driver of the global contrast enhanced ultrasound market. However, the market growth is restrained by difficulty in adopting contrast enhanced ultrasound in the current healthcare system.

REGIONAL INSIGHTS

The geographical analysis of the global contrast enhanced ultrasound market growth includes North America, Europe, Asia-Pacific, and Rest of World. North America is set to garner the largest revenue share in the global market, largely attributed to the growing cases of various health conditions.

COMPETITIVE INSIGHTS

The market is highly fragmented due to the presence of several regional and multinational companies. Some of the leading players in the market include Acusphere Inc, Siemens Healthineers AG, GE Healthcare, Koninklijke Philips NV, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. SURGING PREVALENCE OF CHRONIC DISEASES
    • 3.1.2. HEALTH PRACTITIONERS PREFER CONTRAST ENHANCED ULTRASOUND IMAGING
    • 3.1.3. TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSIS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. NON-UNIFORMITY OF CONTRAST AGENTS
    • 3.2.2. DIFFICULTY IN ADOPTION IN THE CURRENT HEALTHCARE SYSTEM

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON CONTRAST ENHANCED ULTRASOUND MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE
  • 4.6. VALUE CHAIN ANALYSIS
  • 4.7. KEY BUYING CRITERIA
    • 4.7.1. COST EFFICIENCY
    • 4.7.2. PRODUCT FEATURES
    • 4.7.3. END-USE
  • 4.8. REGULATORY FRAMEWORK

5. MARKET BY PRODUCT

  • 5.1. EQUIPMENT
  • 5.2. CONTRAST AGENT

6. MARKET BY TYPE

  • 6.1. NON-TARGETED
  • 6.2. TARGETED

7. MARKET BY END-USER

  • 7.1. HOSPITALS
  • 7.2. CLINICS
  • 7.3. AMBULATORY DIAGNOSTIC CENTERS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. MARKET SIZE & ESTIMATES
    • 8.1.2. KEY GROWTH ENABLERS
    • 8.1.3. KEY CHALLENGES
    • 8.1.4. KEY PLAYERS
    • 8.1.5. COUNTRY ANALYSIS
      • 8.1.5.1. UNITED STATES
      • 8.1.5.2. CANADA
  • 8.2. EUROPE
    • 8.2.1. MARKET SIZE & ESTIMATES
    • 8.2.2. KEY GROWTH ENABLERS
    • 8.2.3. KEY CHALLENGES
    • 8.2.4. KEY PLAYERS
    • 8.2.5. COUNTRY ANALYSIS
      • 8.2.5.1. UNITED KINGDOM
      • 8.2.5.2. GERMANY
      • 8.2.5.3. FRANCE
      • 8.2.5.4. ITALY
      • 8.2.5.5. SPAIN
      • 8.2.5.6. NORDIC COUNTRIES
      • 8.2.5.7. REST OF EUROPE
  • 8.3. ASIA-PACIFIC
    • 8.3.1. MARKET ESTIMATES & SIZES
    • 8.3.2. KEY GROWTH ENABLERS
    • 8.3.3. KEY CHALLENGES
    • 8.3.4. KEY PLAYERS
    • 8.3.5. COUNTRY ANALYSIS
      • 8.3.5.1. CHINA
      • 8.3.5.2. JAPAN
      • 8.3.5.3. INDIA
      • 8.3.5.4. SOUTH KOREA
      • 8.3.5.5. INDONESIA
      • 8.3.5.6. SINGAPORE
      • 8.3.5.7. TAIWAN
      • 8.3.5.8. AUSTRALIA & NEW ZEALAND
      • 8.3.5.9. REST OF ASIA-PACIFIC
  • 8.4. REST OF WORLD
    • 8.4.1. MARKET ESTIMATES & SIZES
    • 8.4.2. KEY GROWTH ENABLERS
    • 8.4.3. KEY CHALLENGES
    • 8.4.4. KEY PLAYERS
    • 8.4.5. REGIONAL ANALYSIS
      • 8.4.5.1. LATIN AMERICA
      • 8.4.5.2. MIDDLE EAST & AFRICA

9. COMPETITIVE LANDSCAPE

  • 9.1. KEY STRATEGIC DEVELOPMENTS
    • 9.1.1. MERGERS & ACQUISITIONS
    • 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 9.1.3. PARTNERSHIPS & AGREEMENTS
    • 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
  • 9.2. COMPANY PROFILES
    • 9.2.1. BAYER AG
    • 9.2.2. BRACCO DIAGNOSTIC INC
    • 9.2.3. DAIICHI SANKYO COMPANY LIMITED
    • 9.2.4. GE HEALTHCARE
    • 9.2.5. KONINKLIJKE PHILIPS NV
    • 9.2.6. LANTHEUS MEDICAL IMAGING INC
    • 9.2.7. NANOPET PHARMA GMBH
    • 9.2.8. SANOCHEMIA PHARMAZEUTIKA GMBH
    • 9.2.9. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
    • 9.2.10. SIEMENS HEALTHINEERS AG
    • 9.2.11. TAEJOON PHARM
    • 9.2.12. TRIVITRON HEALTHCARE